glp 1 agonist probiotic GLP-1 A+ Pendulum Therapeutics Introduces GLP-1 Probiotic

The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.

(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists

Medicaid coverage for GLP-1 drugs varies significantly by state and plan, with most programs requiring prior authorization and medical documentation of BMI, comorbidities, or failed weight loss attempts

In the T2D study, HbA1c improved by 2.2%, with 82% of participants reaching HbA1c6.5%

Supports gut lining integrity

78.64.4 l/min/gkw, sodium excretion 7.40.8 vs